Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biosimilar Monoclonal Antibodies market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biosimilar Monoclonal Antibodies market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar Monoclonal Antibodies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celgen Biopharma
Celltrion
3SBIO
Torrent Pharmaceuticals
Dr Reddy’s
Pfizer (Hospira)
Cadila Healthcare
Hisun Pharma
Novartis (Sandoz)
By Type:
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
By End-User:
Oncology
Autoimmune Disease
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Monoclonal Antibodies Market
-
1.3 Market Segment by Type
-
1.3.1 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Infliximab from 2016 to 2027
-
1.3.2 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Rituximab from 2016 to 2027
-
1.3.3 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Trastuzumab from 2016 to 2027
-
1.3.4 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Adalimumab from 2016 to 2027
-
1.3.5 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027
-
1.4.3 USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilar Monoclonal Antibodies Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilar Monoclonal Antibodies by Major Types
-
3.4.1 Market Size and Growth Rate of Infliximab
-
3.4.2 Market Size and Growth Rate of Rituximab
-
3.4.3 Market Size and Growth Rate of Trastuzumab
-
3.4.4 Market Size and Growth Rate of Adalimumab
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Biosimilar Monoclonal Antibodies Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilar Monoclonal Antibodies by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilar Monoclonal Antibodies in Oncology
-
4.4.2 Market Size and Growth Rate of Biosimilar Monoclonal Antibodies in Autoimmune Disease
-
4.4.3 Market Size and Growth Rate of Biosimilar Monoclonal Antibodies in Other
5 Market Analysis by Regions
-
5.1 USA Biosimilar Monoclonal Antibodies Production Analysis by Regions
-
5.2 USA Biosimilar Monoclonal Antibodies Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Biosimilar Monoclonal Antibodies Landscape Analysis
-
6.1 West USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major Types
-
6.2 West USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major End-Users
7 South USA Biosimilar Monoclonal Antibodies Landscape Analysis
-
7.1 South USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major Types
-
7.2 South USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major End-Users
8 Middle West USA Biosimilar Monoclonal Antibodies Landscape Analysis
-
8.1 Middle West USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major Types
-
8.2 Middle West USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major End-Users
9 Northeast USA Biosimilar Monoclonal Antibodies Landscape Analysis
-
9.1 Northeast USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major Types
-
9.2 Northeast USA Biosimilar Monoclonal Antibodies Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Celgen Biopharma
-
10.1.1 Celgen Biopharma Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Celltrion
-
10.2.1 Celltrion Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 3SBIO
-
10.3.1 3SBIO Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Torrent Pharmaceuticals
-
10.4.1 Torrent Pharmaceuticals Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Dr Reddy’s
-
10.5.1 Dr Reddy’s Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Pfizer (Hospira)
-
10.6.1 Pfizer (Hospira) Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Cadila Healthcare
-
10.7.1 Cadila Healthcare Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Hisun Pharma
-
10.8.1 Hisun Pharma Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis (Sandoz)
-
10.9.1 Novartis (Sandoz) Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Infliximab from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Rituximab from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Trastuzumab from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Adalimumab from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027
-
Figure USA Biosimilar Monoclonal Antibodies Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilar Monoclonal Antibodies Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilar Monoclonal Antibodies
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilar Monoclonal Antibodies by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilar Monoclonal Antibodies by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Infliximab
-
Figure Market Size and Growth Rate of Rituximab
-
Figure Market Size and Growth Rate of Trastuzumab
-
Figure Market Size and Growth Rate of Adalimumab
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilar Monoclonal Antibodies by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilar Monoclonal Antibodies by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Autoimmune Disease
-
Figure Market Size and Growth Rate of Other
-
Table USA Biosimilar Monoclonal Antibodies Production by Regions
-
Table USA Biosimilar Monoclonal Antibodies Production Share by Regions
-
Figure USA Biosimilar Monoclonal Antibodies Production Share by Regions in 2016
-
Figure USA Biosimilar Monoclonal Antibodies Production Share by Regions in 2021
-
Figure USA Biosimilar Monoclonal Antibodies Production Share by Regions in 2027
-
Table USA Biosimilar Monoclonal Antibodies Consumption by Regions
-
Table USA Biosimilar Monoclonal Antibodies Consumption Share by Regions
-
Figure USA Biosimilar Monoclonal Antibodies Consumption Share by Regions in 2016
-
Figure USA Biosimilar Monoclonal Antibodies Consumption Share by Regions in 2021
-
Figure USA Biosimilar Monoclonal Antibodies Consumption Share by Regions in 2027
-
Table West USA Biosimilar Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table West USA Biosimilar Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2027
-
Table West USA Biosimilar Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table South USA Biosimilar Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table South USA Biosimilar Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2027
-
Table South USA Biosimilar Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table South USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure South USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Middle West USA Biosimilar Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Middle West USA Biosimilar Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Middle West USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Northeast USA Biosimilar Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Northeast USA Biosimilar Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Northeast USA Biosimilar Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celgen Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgen Biopharma
-
Figure Sales and Growth Rate Analysis of Celgen Biopharma
-
Figure Revenue and Market Share Analysis of Celgen Biopharma
-
Table Product and Service Introduction of Celgen Biopharma
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of 3SBIO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBIO
-
Figure Sales and Growth Rate Analysis of 3SBIO
-
Figure Revenue and Market Share Analysis of 3SBIO
-
Table Product and Service Introduction of 3SBIO
-
Table Company Profile and Development Status of Torrent Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Torrent Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Torrent Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Torrent Pharmaceuticals
-
Table Product and Service Introduction of Torrent Pharmaceuticals
-
Table Company Profile and Development Status of Dr Reddy’s
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s
-
Figure Sales and Growth Rate Analysis of Dr Reddy’s
-
Figure Revenue and Market Share Analysis of Dr Reddy’s
-
Table Product and Service Introduction of Dr Reddy’s
-
Table Company Profile and Development Status of Pfizer (Hospira)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (Hospira)
-
Figure Sales and Growth Rate Analysis of Pfizer (Hospira)
-
Figure Revenue and Market Share Analysis of Pfizer (Hospira)
-
Table Product and Service Introduction of Pfizer (Hospira)
-
Table Company Profile and Development Status of Cadila Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cadila Healthcare
-
Figure Sales and Growth Rate Analysis of Cadila Healthcare
-
Figure Revenue and Market Share Analysis of Cadila Healthcare
-
Table Product and Service Introduction of Cadila Healthcare
-
Table Company Profile and Development Status of Hisun Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hisun Pharma
-
Figure Sales and Growth Rate Analysis of Hisun Pharma
-
Figure Revenue and Market Share Analysis of Hisun Pharma
-
Table Product and Service Introduction of Hisun Pharma
-
Table Company Profile and Development Status of Novartis (Sandoz)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)
-
Figure Sales and Growth Rate Analysis of Novartis (Sandoz)
-
Figure Revenue and Market Share Analysis of Novartis (Sandoz)
-
Table Product and Service Introduction of Novartis (Sandoz)
-
